Sarah Cannon Research Institute - Dallas

Site:	Sarah Cannon Research Institute - Dallas
Address:
City:	Dallas
State:	TX
Zip:	75230
Country:	USA

Phase	Trial [asc]	Trial Status	Site Status	Drug	NCT#
1	A Study of Ziftomenib, an Oral Menin Inhibitor, in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)	Recruiting	Active	Ziftomenib + Imatinib	NCT06655246